| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 FSTL4 ADGRV1 C2CD5 FAT2 DST ACAN ADGRE3 PCDH15 ANXA9 HSPG2 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 SUSD1 PCDHGA12 VCAN LRP1 LTBP2 LTBP3 PCDH7 PCDHGA8 | 6.73e-10 | 749 | 191 | 28 | GO:0005509 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP1B MYO9A RPS3 ADGRV1 PARVG MAP3K1 DST AP1G1 FAM161A SVIL SYNE2 FAM110C VCL ANK3 EPB41L4B SYNM BAG2 MYO18A APC XIRP2 TTLL2 AVIL TOR1AIP1 MX1 | 1.37e-04 | 1099 | 191 | 24 | GO:0008092 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PECAM1 KIRREL3 FAT2 PKD1 PCDH15 CNTN2 PLXNB3 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y NPTN CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 4.32e-17 | 187 | 189 | 21 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PECAM1 KIRREL3 FAT2 PKD1 PCDH15 CNTN2 PLXNB3 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y GRID2 NPTN CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 1.42e-13 | 313 | 189 | 22 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 RPS3 PIEZO1 PECAM1 NFASC ADGRV1 KIRREL3 FAT2 PKD1 PCDH15 ANXA9 CNTN2 PLXNB3 VCL HSPD1 FAT4 KAT5 ANK3 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y ITGA10 GRID2 RPSA ARG1 NPTN CELSR1 CELSR3 CELSR2 PCDHGA12 SMARCE1 PARD3 PCDH7 PCDHGA8 | 1.20e-11 | 1077 | 189 | 36 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron projection development | MAP1B MYCBP2 MYO9A FSTL4 NFASC ADGRV1 KIRREL3 DST ANAPC2 PCDH15 CNTN2 PLXNB3 VCL HSPG2 FAT4 ANK3 FAT3 DVL2 APC LAMB3 GRID2 SPG11 FRYL NPTN CELSR3 CELSR2 TNN AVIL LRP1 PARD3 | 2.11e-06 | 1285 | 189 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MAP1B MYCBP2 MYO9A PECAM1 FSTL4 NFASC MAP3K1 KIRREL3 DST ANAPC2 PCDH15 CNTN2 PLXNB3 VCL HSPG2 ANK3 FAT3 DVL2 APC LAMB3 SPG11 FRYL JMJD1C CELSR3 CELSR2 TNN LRP1 PARD3 | 4.44e-06 | 1194 | 189 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MAP1B MYCBP2 MYO9A FSTL4 NFASC KIRREL3 DST ANAPC2 CNTN2 PLXNB3 VCL HSPG2 ANK3 DVL2 APC LAMB3 SPG11 CELSR3 CELSR2 TNN LRP1 PARD3 | 4.64e-06 | 802 | 189 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | MAP1B MYCBP2 FSTL4 NFASC DST ANAPC2 CNTN2 PLXNB3 VCL HSPG2 ANK3 APC LAMB3 SPG11 CELSR3 TNN LRP1 PARD3 | 4.94e-06 | 566 | 189 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAP1B MYCBP2 FSTL4 NFASC DST ANAPC2 PCDH15 CNTN2 PLXNB3 VCL HSPG2 ANK3 FAT3 APC LAMB3 SPG11 CELSR3 CELSR2 TNN LRP1 PARD3 | 5.44e-06 | 748 | 189 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MAP1B MYCBP2 MYO9A FSTL4 NFASC KIRREL3 DST ANAPC2 CNTN2 PLXNB3 VCL HSPG2 ANK3 DVL2 APC LAMB3 SPG11 CELSR3 CELSR2 TNN LRP1 PARD3 | 6.47e-06 | 819 | 189 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MAP1B MYCBP2 MYO9A FSTL4 NFASC KIRREL3 DST ANAPC2 CNTN2 PLXNB3 VCL HSPG2 ANK3 DVL2 APC LAMB3 SPG11 CELSR3 CELSR2 TNN LRP1 PARD3 | 7.40e-06 | 826 | 189 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron development | MAP1B MYCBP2 MYO9A FSTL4 NFASC ADGRV1 KIRREL3 DST ANAPC2 PCDH15 CNTN2 PLXNB3 VCL HSPG2 FAT4 ANK3 HTRA2 FAT3 DVL2 APC LAMB3 GRID2 SPG11 FRYL NPTN CELSR3 CELSR2 TNN AVIL LRP1 PARD3 | 1.01e-05 | 1463 | 189 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon development | MAP1B MYCBP2 FSTL4 NFASC DST ANAPC2 CNTN2 PLXNB3 VCL HSPG2 ANK3 APC LAMB3 SPG11 CELSR3 TNN LRP1 PARD3 | 2.69e-05 | 642 | 189 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric | 8.35e-05 | 2 | 189 | 2 | GO:1904908 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of mitotic sister chromatid cohesion, telomeric | 8.35e-05 | 2 | 189 | 2 | GO:1904907 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, telomeric | 8.35e-05 | 2 | 189 | 2 | GO:0099404 | |
| GeneOntologyBiologicalProcess | maintenance of mitotic sister chromatid cohesion, telomeric | 8.35e-05 | 2 | 189 | 2 | GO:0099403 | |
| GeneOntologyBiologicalProcess | microtubule-based process | HIF1A ATRX MAP1B RPS3 NUBP1 CNTLN FSIP2 DST SYNE2 PKD1 DYNLRB2 CNTN2 KAT5 ANK3 APC SPG11 AAAS CELSR2 TTLL2 TNKS PARD3 SEPTIN12 CHMP1A | 1.08e-04 | 1058 | 189 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ATRX MAP1B RPS3 NUBP1 CNTLN FSIP2 DST SYNE2 PKD1 CNTN2 KAT5 ANK3 APC AAAS TTLL2 TNKS PARD3 CHMP1A | 1.17e-04 | 720 | 189 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | protein localization to axon | 1.18e-04 | 11 | 189 | 3 | GO:0099612 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 1.35e-04 | 257 | 189 | 10 | GO:0007163 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | HIF1A ATRX MAP1B MYCBP2 RPS3 PECAM1 NUBP1 MAP3K1 C2CD5 ANAPC1 SVIL SYNE2 ANAPC2 PKD1 KAT5 HTRA2 DVL2 APC GRID2 CELSR1 XIRP2 AVIL LRP1 SMARCE1 TNKS CHMP1A | 2.40e-04 | 1342 | 189 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell junction organization | MAP1B MYCBP2 MYO9A PECAM1 ADGRB2 NFASC KIRREL3 DST ANAPC2 CNTN2 VCL ANK3 DSG1 APC GRID1 GRID2 SPG11 NPTN XIRP2 LRP1 PARD3 | 2.46e-04 | 974 | 189 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell-cell junction | 2.49e-04 | 3 | 189 | 2 | GO:0150106 | |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of sister chromatid cohesion | 2.49e-04 | 3 | 189 | 2 | GO:0034092 | |
| GeneOntologyBiologicalProcess | negative regulation of maintenance of mitotic sister chromatid cohesion | 2.49e-04 | 3 | 189 | 2 | GO:0034183 | |
| GeneOntologyBiologicalProcess | cell junction assembly | MAP1B MYCBP2 MYO9A PECAM1 ADGRB2 NFASC KIRREL3 DST VCL DSG1 APC GRID2 NPTN LRP1 PARD3 | 2.50e-04 | 569 | 189 | 15 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MAP1B MYCBP2 RPS3 PECAM1 NUBP1 MAP3K1 SVIL PKD1 DVL2 APC CELSR1 XIRP2 AVIL LRP1 CHMP1A | 3.01e-04 | 579 | 189 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | motor neuron migration | 3.18e-04 | 15 | 189 | 3 | GO:0097475 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 RPS3 PECAM1 NFASC PARVG KIAA1210 KIRREL3 FAT2 DST ARHGAP31 SVIL SYNE2 VCL HSPG2 ANK3 DSG1 EPB41L4B SYNM APC PANX2 XIRP2 PCDHGA12 AVIL LRP1 PARD3 | 3.87e-06 | 976 | 193 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | costamere | 4.52e-05 | 22 | 193 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 PECAM1 NFASC KIAA1210 KIRREL3 FAT2 DST VCL ANK3 DSG1 EPB41L4B SYNM APC PANX2 PCDHGA12 PARD3 | 1.26e-04 | 591 | 193 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.88e-04 | 90 | 193 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | sperm midpiece | 3.12e-04 | 64 | 193 | 5 | GO:0097225 | |
| GeneOntologyCellularComponent | piccolo histone acetyltransferase complex | 5.03e-04 | 4 | 193 | 2 | GO:0032777 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.28e-04 | 109 | 193 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | axon | HIF1A MAP1B MYCBP2 MYO9A NFASC STAT1 KIRREL3 DST KCNK2 CNTN2 DRD5 ANK3 BAG2 APC SPG11 TNN AVIL LRP1 PARD3 | 6.17e-04 | 891 | 193 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | focal adhesion | RPS3 NFASC PARVG DST ARHGAP31 SVIL SYNE2 VCL HSPG2 XIRP2 AVIL LRP1 | 6.96e-04 | 431 | 193 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | axonal growth cone | 7.81e-04 | 45 | 193 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | node of Ranvier | 7.87e-04 | 20 | 193 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | cell-substrate junction | RPS3 NFASC PARVG DST ARHGAP31 SVIL SYNE2 VCL HSPG2 XIRP2 AVIL LRP1 | 8.84e-04 | 443 | 193 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | basement membrane | 9.55e-04 | 122 | 193 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MAP1B RPS3 NFASC STAT1 KIRREL3 ACAN KCNK2 CNTN2 DRD5 ANK3 FAT3 BAG2 APC GRID2 SPG11 RPSA PEX5L ARG1 NPTN TNN LRP1 GIGYF2 PARD3 | 9.92e-04 | 1228 | 193 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | main axon | 1.41e-03 | 89 | 193 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.56e-03 | 349 | 193 | 10 | GO:0031965 | |
| GeneOntologyCellularComponent | cilium | HIF1A PTCHD3 MAP1B NUBP1 ADGRV1 FSIP2 FAM161A PKD1 PCDH15 DYNLRB2 HSPD1 DRD5 TCP11 PCDH11Y KIAA1549 TTLL2 VCAN SEPTIN12 | 1.72e-03 | 898 | 193 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 1.73e-03 | 7 | 193 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.86e-03 | 139 | 193 | 6 | GO:0097733 | |
| Domain | Cadherin_CS | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 3.53e-13 | 109 | 191 | 15 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 6.06e-13 | 113 | 191 | 15 | PS00232 |
| Domain | Cadherin | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 6.06e-13 | 113 | 191 | 15 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 6.92e-13 | 114 | 191 | 15 | PS50268 |
| Domain | - | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 6.92e-13 | 114 | 191 | 15 | 2.60.40.60 |
| Domain | CA | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 7.89e-13 | 115 | 191 | 15 | SM00112 |
| Domain | Cadherin-like | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 8.98e-13 | 116 | 191 | 15 | IPR015919 |
| Domain | Cadherin | DCHS2 FAT2 PCDH15 FAT4 DSG1 PCDHGA10 PCDHGA7 FAT3 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 1.16e-12 | 118 | 191 | 15 | IPR002126 |
| Domain | EGF_CA | FAT2 ADGRE3 HSPG2 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 VCAN LRP1 LTBP2 LTBP3 | 3.69e-10 | 122 | 191 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FAT2 ADGRE3 HSPG2 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 VCAN LRP1 LTBP2 LTBP3 | 4.52e-10 | 124 | 191 | 13 | IPR001881 |
| Domain | GPS | 1.49e-09 | 34 | 191 | 8 | SM00303 | |
| Domain | GPS | 1.92e-09 | 35 | 191 | 8 | PF01825 | |
| Domain | GPS | 2.45e-09 | 36 | 191 | 8 | PS50221 | |
| Domain | GPS | 3.09e-09 | 37 | 191 | 8 | IPR000203 | |
| Domain | ASX_HYDROXYL | ADGRE3 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 VCAN LRP1 LTBP2 LTBP3 | 6.15e-09 | 100 | 191 | 11 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | ADGRE3 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 VCAN LRP1 LTBP2 LTBP3 | 1.15e-08 | 106 | 191 | 11 | IPR000152 |
| Domain | EGF | FAT2 MUC17 ADGRE3 HSPG2 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 2.02e-08 | 235 | 191 | 15 | SM00181 |
| Domain | EGF_3 | FAT2 MUC17 ADGRE3 HSPG2 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 2.02e-08 | 235 | 191 | 15 | PS50026 |
| Domain | EGF-like_dom | FAT2 MUC17 ADGRE3 HSPG2 FAT4 FAT3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 4.36e-08 | 249 | 191 | 15 | IPR000742 |
| Domain | GAIN_dom_N | 4.67e-08 | 11 | 191 | 5 | IPR032471 | |
| Domain | GAIN | 4.67e-08 | 11 | 191 | 5 | PF16489 | |
| Domain | EGF_1 | FAT2 MUC17 HSPG2 FAT4 FAT3 LAMB3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 5.96e-08 | 255 | 191 | 15 | PS00022 |
| Domain | EGF-like_CS | FAT2 MUC17 HSPG2 FAT4 FAT3 LAMB3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 8.09e-08 | 261 | 191 | 15 | IPR013032 |
| Domain | EGF_2 | FAT2 MUC17 HSPG2 FAT4 FAT3 LAMB3 CELSR1 CELSR3 CELSR2 SUSD1 TNN VCAN LRP1 LTBP2 LTBP3 | 9.87e-08 | 265 | 191 | 15 | PS01186 |
| Domain | LAM_G_DOMAIN | 1.01e-07 | 38 | 191 | 7 | PS50025 | |
| Domain | Laminin_G_2 | 1.47e-07 | 40 | 191 | 7 | PF02210 | |
| Domain | LamG | 2.92e-07 | 44 | 191 | 7 | SM00282 | |
| Domain | - | 5.58e-07 | 95 | 191 | 9 | 2.60.120.200 | |
| Domain | 7tm_2 | 7.22e-07 | 50 | 191 | 7 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 7.22e-07 | 50 | 191 | 7 | PS00650 | |
| Domain | Laminin_G | 2.03e-06 | 58 | 191 | 7 | IPR001791 | |
| Domain | GPCR_2_secretin-like | 2.56e-06 | 60 | 191 | 7 | IPR000832 | |
| Domain | GPCR_2-like | 2.56e-06 | 60 | 191 | 7 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.87e-06 | 61 | 191 | 7 | PS50261 | |
| Domain | GPCR_2_extracellular_dom | 3.04e-06 | 40 | 191 | 6 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.04e-06 | 40 | 191 | 6 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.04e-06 | 40 | 191 | 6 | PS50227 | |
| Domain | Growth_fac_rcpt_ | 4.76e-06 | 156 | 191 | 10 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 6.86e-06 | 97 | 191 | 8 | IPR018097 | |
| Domain | EGF_CA | 7.99e-06 | 99 | 191 | 8 | PS01187 | |
| Domain | EGF_LAM_2 | 1.23e-05 | 30 | 191 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 1.23e-05 | 30 | 191 | 5 | PS01248 | |
| Domain | EGF_Lam | 2.69e-05 | 35 | 191 | 5 | SM00180 | |
| Domain | Laminin_EGF | 2.69e-05 | 35 | 191 | 5 | PF00053 | |
| Domain | EGF_CA | 2.85e-05 | 86 | 191 | 7 | PF07645 | |
| Domain | Laminin_EGF | 4.05e-05 | 38 | 191 | 5 | IPR002049 | |
| Domain | EGF | 4.64e-05 | 126 | 191 | 8 | PF00008 | |
| Domain | Cadherin_2 | 5.29e-05 | 65 | 191 | 6 | PF08266 | |
| Domain | Cadherin_N | 5.29e-05 | 65 | 191 | 6 | IPR013164 | |
| Domain | HormR | 1.13e-04 | 25 | 191 | 4 | SM00008 | |
| Domain | HRM | 1.79e-04 | 28 | 191 | 4 | PF02793 | |
| Domain | Gelsolin | 3.53e-04 | 14 | 191 | 3 | PF00626 | |
| Domain | Gelsolin-like_dom | 3.53e-04 | 14 | 191 | 3 | IPR007123 | |
| Domain | SEA | 3.53e-04 | 14 | 191 | 3 | SM00200 | |
| Domain | ConA-like_dom | 4.34e-04 | 219 | 191 | 9 | IPR013320 | |
| Domain | Cadherin_tail | 5.38e-04 | 37 | 191 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 5.38e-04 | 37 | 191 | 4 | IPR031904 | |
| Domain | VWF_A | 5.39e-04 | 99 | 191 | 6 | IPR002035 | |
| Domain | Ubiquitin-rel_dom | 6.24e-04 | 184 | 191 | 8 | IPR029071 | |
| Domain | Cadherin_C | 8.75e-04 | 42 | 191 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 8.75e-04 | 42 | 191 | 4 | PF16492 | |
| Domain | Protocadherin | 1.02e-03 | 5 | 191 | 2 | PF08374 | |
| Domain | Protocadherin | 1.02e-03 | 5 | 191 | 2 | IPR013585 | |
| Domain | SEA | 1.40e-03 | 22 | 191 | 3 | PF01390 | |
| Domain | SEA | 1.60e-03 | 23 | 191 | 3 | PS50024 | |
| Domain | SEA_dom | 1.60e-03 | 23 | 191 | 3 | IPR000082 | |
| Domain | - | 1.82e-03 | 24 | 191 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 1.82e-03 | 24 | 191 | 3 | IPR029006 | |
| Domain | TB | 2.11e-03 | 7 | 191 | 2 | PF00683 | |
| Domain | HP | 2.80e-03 | 8 | 191 | 2 | PS51089 | |
| Domain | - | 2.80e-03 | 8 | 191 | 2 | 1.10.950.10 | |
| Domain | Villin/Gelsolin | 2.80e-03 | 8 | 191 | 2 | IPR007122 | |
| Domain | - | 2.80e-03 | 8 | 191 | 2 | 3.90.290.10 | |
| Domain | VHP | 2.80e-03 | 8 | 191 | 2 | SM00153 | |
| Domain | K_chnl_volt-dep_Kv1 | 2.80e-03 | 8 | 191 | 2 | IPR003972 | |
| Domain | VHP | 2.80e-03 | 8 | 191 | 2 | PF02209 | |
| Domain | Villin_headpiece | 2.80e-03 | 8 | 191 | 2 | IPR003128 | |
| Domain | GEL | 2.80e-03 | 8 | 191 | 2 | SM00262 | |
| Domain | hEGF | 2.86e-03 | 28 | 191 | 3 | PF12661 | |
| Domain | IGc2 | 2.95e-03 | 235 | 191 | 8 | SM00408 | |
| Domain | Ig_sub2 | 2.95e-03 | 235 | 191 | 8 | IPR003598 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 1.95e-05 | 17 | 139 | 4 | M39525 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | FAT2 PCDHGA10 PCDHGA7 PCDH11Y CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 3.15e-11 | 80 | 197 | 10 | 10716726 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NR2C2 DPY19L3 EMC4 MAP1B MYCBP2 PIEZO1 FSTL4 FKBP11 SIAE MANEAL SVIL EMG1 SUCO HSPG2 COL7A1 FAT4 EDC3 KIAA1549 LAMB3 NPTN CELSR1 CELSR3 CELSR2 LRP1 SMARCE1 LTBP2 LTBP3 PCDH7 TOR1AIP1 | 5.03e-11 | 1201 | 197 | 29 | 35696571 |
| Pubmed | SEC24A SVIL ZNF638 ANK3 EPB41L4B SYNM DVL2 APC KIAA1549 JMJD1C TMEM209 GIGYF2 PARD3 TOR1AIP1 | 3.92e-10 | 263 | 197 | 14 | 34702444 | |
| Pubmed | FAT2 PCDHGA10 PCDHGA7 PCDH11Y CELSR1 CELSR2 PCDHGA12 PCDH7 PCDHGA8 | 5.78e-10 | 77 | 197 | 9 | 10835267 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 6.34e-10 | 33 | 197 | 7 | 25713288 | |
| Pubmed | NCOA6 ATRX MYCBP2 AUP1 PECAM1 SYTL2 DST AP1G1 ANAPC2 PKD1 VCL HSPG2 ANK3 UBXN11 SUSD1 LRP1 SMARCE1 ASXL2 LTBP3 | 1.43e-09 | 591 | 197 | 19 | 15231748 | |
| Pubmed | TET2 NCOA6 NR2C2 ATRX DIS3L SEC24A STAT1 LARP4B DST NFIC ZMIZ2 SVIL SYNE2 ZNF638 VCL HSPD1 HSPG2 EDC3 KAT5 BAG2 MYO18A RPSA JMJD1C EPC1 GIGYF2 SMARCE1 ASXL2 PCDH7 LRIF1 | 2.74e-09 | 1429 | 197 | 29 | 35140242 | |
| Pubmed | MAP1B AUP1 MYO9A RPS3 SEC24A STAT1 DST VCL HSPD1 EDC3 ANK3 BAG2 USP24 DVL2 APC JMJD1C USO1 GIGYF2 PARD3 PCDH7 | 4.66e-09 | 708 | 197 | 20 | 39231216 | |
| Pubmed | 6.87e-09 | 13 | 197 | 5 | 26989192 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 8.07e-09 | 72 | 197 | 8 | 10380929 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 NR2C2 EME1 HIF1A ATRX AUP1 FKBP11 DST INTS2 ANAPC1 NFIC ANAPC2 INTS11 ZNF638 TET3 HSPD1 KAT5 BAG2 JMJD1C AAAS EPC1 TMEM209 SMARCE1 ASXL2 TOR1AIP1 LRIF1 | 2.41e-08 | 1294 | 197 | 26 | 30804502 |
| Pubmed | 3.45e-08 | 7 | 197 | 4 | 16059920 | ||
| Pubmed | BRIP1 MYCBP2 SYTL2 LARP4B ANAPC1 ZNF638 VCL CCDC22 EDC3 BAG2 APC SPG11 JMJD1C NPTN AAAS USO1 TMEM209 TOR1AIP1 CHMP1A | 4.50e-08 | 733 | 197 | 19 | 34672954 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 19669783 | ||
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 11677057 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 EME1 BRIP1 ATRX MYCBP2 RPS3 C2CD5 ANAPC1 NFIC SVIL ZNF638 ANXA9 DHX16 USP24 MYO18A GIGYF2 PARD3 PCDH7 | 5.04e-07 | 774 | 197 | 18 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 NCOA6 MAP1B MYCBP2 MYO9A SEC24A FSIP2 DST KCNA7 SVIL SYNE2 EDC3 APC FRYL USO1 GIGYF2 SRPK3 PARD3 PCDH7 | 5.28e-07 | 861 | 197 | 19 | 36931259 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.43e-07 | 123 | 197 | 8 | 26912792 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 5.89e-07 | 29 | 197 | 5 | 15203201 | |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 7.13e-07 | 4 | 197 | 3 | 37224017 | |
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 7.13e-07 | 4 | 197 | 3 | 11850187 | |
| Pubmed | TET2 NR2C2 MYCBP2 DST ANAPC1 ZMIZ2 USP24 DVL2 APC JMJD1C USO1 LRP1 GIGYF2 | 8.89e-07 | 418 | 197 | 13 | 34709266 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.16e-06 | 184 | 197 | 9 | 32908313 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | RPS3 LARP4B SYNE2 SUCO DVL2 RPSA JMJD1C NPTN AAAS TMEM209 GIGYF2 TOR1AIP1 | 1.76e-06 | 375 | 197 | 12 | 32788342 |
| Pubmed | 2.10e-06 | 103 | 197 | 7 | 10574462 | ||
| Pubmed | TET2 NCOA6 PIEZO1 NFASC ADGRV1 NACAD DST INTS2 ARHGAP31 ANAPC2 KIAA1549 SPG11 CELSR3 DEPDC5 | 2.24e-06 | 529 | 197 | 14 | 14621295 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.29e-06 | 67 | 197 | 6 | 21875946 | |
| Pubmed | AUP1 RPS3 SEC24A DST ZNF638 HSPD1 FAT4 EDC3 ANK3 EPB41L4B SYNM APC MUC16 USO1 PARD3 PCDH7 TOR1AIP1 | 2.41e-06 | 777 | 197 | 17 | 35844135 | |
| Pubmed | MYCBP2 NHSL2 ADGRB2 NFASC DST ANAPC1 SVIL SYNE2 ANK3 DVL2 APC PEX5L NPTN CELSR2 LRP1 GIGYF2 TNKS FRMPD3 PARD3 | 2.74e-06 | 963 | 197 | 19 | 28671696 | |
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 2.87e-06 | 18 | 197 | 4 | 33108146 | |
| Pubmed | NCOA6 MAP1B MYCBP2 RPS3 STAT1 ANAPC1 VCL CCDC22 ANK3 USP24 JMJD1C GIGYF2 SMARCE1 PARD3 | 3.43e-06 | 549 | 197 | 14 | 38280479 | |
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 9486530 | ||
| Pubmed | ATRX UNC13D ZCCHC2 STAT1 C2CD5 SIAE LARP4B INTS2 AP1G1 ZNF638 CRYBG1 SUCO EDC3 ANK3 EPB41L4B APC FRYL VCAN ASXL2 PARD3 | 4.04e-06 | 1084 | 197 | 20 | 11544199 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 4.12e-06 | 74 | 197 | 6 | 10817752 | |
| Pubmed | NR2C2 CPNE8 EMC4 ATRX MYCBP2 AUP1 PIEZO1 C2CD5 PNPT1 SYNE2 EMG1 SUCO VCL HSPD1 ANK3 SYNM BAG2 MYO18A KIAA1549 SPG11 TMEM209 PARD3 PCDH7 TOR1AIP1 | 4.19e-06 | 1487 | 197 | 24 | 33957083 | |
| Pubmed | ATRX MAP1B DST AP1G1 ANAPC2 ZNF638 EMG1 DHX16 EPB41L4B APC LAMB3 JMJD1C GIGYF2 GALNT6 PLCE1 | 5.11e-06 | 650 | 197 | 15 | 38777146 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SDSL NCOA6 MYCBP2 PIEZO1 ADGRB2 ZNF236 DST ZMIZ2 INTS11 PKD1 HSPG2 LAMB3 GRID1 RPSA FRYL CELSR1 CELSR3 CELSR2 DEPDC5 LTBP3 | 5.36e-06 | 1105 | 197 | 20 | 35748872 |
| Pubmed | Osteoclasts adapt to physioxia perturbation through DNA demethylation. | 6.16e-06 | 7 | 197 | 3 | 34661337 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 6.16e-06 | 7 | 197 | 3 | 17937400 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CPNE8 MAP1B MYCBP2 RPS3 STAT1 DST SVIL SYNE2 ZNF638 EMG1 DHX16 HSPD1 DSG1 BAG2 RPSA ARG1 AAAS GIGYF2 TOR1AIP1 | 6.58e-06 | 1024 | 197 | 19 | 24711643 |
| Pubmed | MYO9A ADGRB2 NFASC ADGRV1 NWD2 ACAN VCL MYO18A APC KIAA1549 VCAN PARD3 | 7.10e-06 | 430 | 197 | 12 | 32581705 | |
| Pubmed | 8.29e-06 | 234 | 197 | 9 | 36243803 | ||
| Pubmed | DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. | 9.82e-06 | 8 | 197 | 3 | 28614801 | |
| Pubmed | 1.23e-05 | 187 | 197 | 8 | 26460568 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | NCOA6 CPNE8 MAP1B RPS3 NFASC DST AP1G1 HSPD1 MYO18A GRID2 RPSA PEX5L SFXN5 PARD3 | 1.38e-05 | 621 | 197 | 14 | 22794259 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MAP1B MYCBP2 RPS3 FKBP11 PNPT1 NWD2 DST INTS11 PCDH15 ZNF638 DHX16 HSPD1 KAT5 MYO18A APC RPSA ARG1 VCAN SMARCE1 | 1.42e-05 | 1082 | 197 | 19 | 38697112 |
| Pubmed | 1.47e-05 | 9 | 197 | 3 | 9693030 | ||
| Pubmed | Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression. | 2.09e-05 | 10 | 197 | 3 | 32182218 | |
| Pubmed | MAP1B MYCBP2 PNPT1 LARP4B DST ANAPC1 SYNE2 ZNF638 VCL DHX16 USP24 RPSA FRYL GIGYF2 | 2.40e-05 | 653 | 197 | 14 | 22586326 | |
| Pubmed | CPNE8 MYO9A RPS3 MAP3K1 DST HSPD1 HSPG2 ANK3 DSG1 BAG2 MUC16 RPSA ARG1 CIAO2B GIGYF2 CHMP1A | 2.80e-05 | 844 | 197 | 16 | 25963833 | |
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 2.86e-05 | 11 | 197 | 3 | 25024228 | |
| Pubmed | 2.86e-05 | 11 | 197 | 3 | 19416849 | ||
| Pubmed | 2.86e-05 | 11 | 197 | 3 | 18685789 | ||
| Pubmed | Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis. | 3.17e-05 | 32 | 197 | 4 | 23177622 | |
| Pubmed | 3.18e-05 | 347 | 197 | 10 | 17114649 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22970168 | ||
| Pubmed | EPC1/TIP60-Mediated Histone Acetylation Facilitates Spermiogenesis in Mice. | 3.19e-05 | 2 | 197 | 2 | 28694333 | |
| Pubmed | Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. | 3.19e-05 | 2 | 197 | 2 | 27852070 | |
| Pubmed | Human alpha-synemin interacts directly with vinculin and metavinculin. | 3.19e-05 | 2 | 197 | 2 | 18028034 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 10790539 | ||
| Pubmed | Piezo1 integration of vascular architecture with physiological force. | 3.19e-05 | 2 | 197 | 2 | 25119035 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 11932252 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19123465 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 26376118 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 32367481 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 7798248 | ||
| Pubmed | Dvl2 promotes intestinal length and neoplasia in the ApcMin mouse model for colorectal cancer. | 3.19e-05 | 2 | 197 | 2 | 20663899 | |
| Pubmed | Activation of HIF-1α does not increase intestinal tumorigenesis. | 3.19e-05 | 2 | 197 | 2 | 24875099 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 16412436 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 37944084 | ||
| Pubmed | TET proteins regulate Drosha expression and impact microRNAs in iNKT cells. | 3.19e-05 | 2 | 197 | 2 | 39364402 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25056900 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 31625608 | ||
| Pubmed | Effects of an ectodermal microceptor preparation on motor coordination in cerebellar mutant mice. | 3.19e-05 | 2 | 197 | 2 | 7886086 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 27729528 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 32219372 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29417241 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29963618 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23581228 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17620659 | ||
| Pubmed | Identification and characterization of versican/PG-M aggregates in cartilage. | 3.19e-05 | 2 | 197 | 2 | 16648631 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 38179947 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23292348 | ||
| Pubmed | Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma. | 3.19e-05 | 2 | 197 | 2 | 18331784 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 21454812 | ||
| Pubmed | Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction. | 3.19e-05 | 2 | 197 | 2 | 22412020 | |
| Pubmed | Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status. | 3.19e-05 | 2 | 197 | 2 | 32126143 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 18791038 | ||
| Pubmed | Glutamate receptors of the delta family are widely expressed in the adult brain. | 3.19e-05 | 2 | 197 | 2 | 25001082 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23568740 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 30678728 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 9602168 | ||
| Pubmed | Acute loss of TET function results in aggressive myeloid cancer in mice. | 3.19e-05 | 2 | 197 | 2 | 26607761 | |
| Pubmed | Three conformational states of the p300 CH1 domain define its functional properties. | 3.19e-05 | 2 | 197 | 2 | 12924942 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23769655 | ||
| Pubmed | High glucose induced HIF-1α/TREK1 expression and myometrium relaxation during pregnancy. | 3.19e-05 | 2 | 197 | 2 | 36909311 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 15003449 | ||
| Pubmed | PIEZO1 and PECAM1 interact at cell-cell junctions and partner in endothelial force sensing. | 3.19e-05 | 2 | 197 | 2 | 37005489 | |
| Pubmed | Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. | 3.19e-05 | 2 | 197 | 2 | 20844082 | |
| Pubmed | TET2 and TET3 loss disrupts small intestine differentiation and homeostasis. | 3.19e-05 | 2 | 197 | 2 | 37414790 | |
| Interaction | C2CD4B interactions | 7.44e-09 | 44 | 191 | 8 | int:C2CD4B | |
| Interaction | XAGE1A interactions | 1.05e-07 | 41 | 191 | 7 | int:XAGE1A | |
| Interaction | RPS14P3 interactions | 2.02e-07 | 15 | 191 | 5 | int:RPS14P3 | |
| Interaction | DCANP1 interactions | 7.57e-07 | 19 | 191 | 5 | int:DCANP1 | |
| Interaction | UCN3 interactions | 2.13e-06 | 23 | 191 | 5 | int:UCN3 | |
| Interaction | NUP210P1 interactions | 2.65e-06 | 42 | 191 | 6 | int:NUP210P1 | |
| Interaction | LOC254896 interactions | 3.05e-06 | 43 | 191 | 6 | int:LOC254896 | |
| Interaction | RNF43 interactions | SEC24A LARP4B SVIL ZNF638 ANK3 EPB41L4B SYNM BAG2 DVL2 APC KIAA1549 JMJD1C TMEM209 GIGYF2 PARD3 TOR1AIP1 | 3.32e-06 | 427 | 191 | 16 | int:RNF43 |
| Interaction | ADAMTS13 interactions | 4.06e-06 | 26 | 191 | 5 | int:ADAMTS13 | |
| Interaction | CD160 interactions | 5.90e-06 | 48 | 191 | 6 | int:CD160 | |
| Interaction | PCDHGB1 interactions | 8.45e-06 | 77 | 191 | 7 | int:PCDHGB1 | |
| Interaction | DKKL1 interactions | 1.08e-05 | 111 | 191 | 8 | int:DKKL1 | |
| Interaction | NXPH2 interactions | 1.39e-05 | 33 | 191 | 5 | int:NXPH2 | |
| Interaction | LAG3 interactions | 1.69e-05 | 17 | 191 | 4 | int:LAG3 | |
| Interaction | PDGFB interactions | 2.04e-05 | 88 | 191 | 7 | int:PDGFB | |
| Interaction | KCNA3 interactions | MAP1B AUP1 MYO9A RPS3 SEC24A SYTL2 STAT1 DST VCL HSPD1 EDC3 ANK3 BAG2 USP24 DVL2 MYO18A APC JMJD1C USO1 GIGYF2 PARD3 PCDH7 | 2.82e-05 | 871 | 191 | 22 | int:KCNA3 |
| Interaction | RYK interactions | DST FAT4 ANK3 PCDHGA7 FAT3 CELSR1 CELSR3 CELSR2 PCDHGA12 PCDH7 | 3.60e-05 | 212 | 191 | 10 | int:RYK |
| Interaction | PSG8 interactions | 4.12e-05 | 41 | 191 | 5 | int:PSG8 | |
| Interaction | GJA1 interactions | CPNE8 MAP1B AUP1 RPS3 SEC24A DST SYNE2 ANK3 EPB41L4B APC KIAA1549 USO1 TMEM209 TAS1R2 PARD3 PCDH7 TOR1AIP1 | 4.24e-05 | 583 | 191 | 17 | int:GJA1 |
| Interaction | SSX6P interactions | 4.53e-05 | 8 | 191 | 3 | int:SSX6P | |
| Interaction | H2BC9 interactions | EME1 HIF1A ATRX MAP1B RPS3 ADGRG4 FSIP2 DST SVIL DSG1 XIRP2 TNN GIGYF2 DEPDC5 | 9.51e-05 | 446 | 191 | 14 | int:H2BC9 |
| Interaction | CEP170P1 interactions | 1.02e-04 | 113 | 191 | 7 | int:CEP170P1 | |
| Interaction | SFN interactions | TET2 NCOA6 HIF1A MAP1B MYCBP2 MYO9A RPS3 DST NFIC SVIL ZNF638 VCL EDC3 APC RPSA FRYL PARD3 PCDH7 | 1.09e-04 | 692 | 191 | 18 | int:SFN |
| Interaction | TRIM37 interactions | HIF1A RPS3 ARHGAP31 FAM161A SVIL HSPD1 EDC3 KAT5 DSG1 SYNM BAG2 MYO18A JMJD1C ARG1 USO1 LRP1 GIGYF2 | 1.09e-04 | 630 | 191 | 17 | int:TRIM37 |
| Interaction | XCL1 interactions | 1.34e-04 | 28 | 191 | 4 | int:XCL1 | |
| GeneFamily | Cadherin related | 1.77e-07 | 17 | 145 | 5 | 24 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 5.05e-07 | 3 | 145 | 3 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 5.05e-07 | 3 | 145 | 3 | 1189 | |
| GeneFamily | Glutamate ionotropic receptor delta type subunits | 6.39e-05 | 2 | 145 | 2 | 1202 | |
| GeneFamily | Immunoglobulin like domain containing | 1.67e-04 | 193 | 145 | 8 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.79e-04 | 4 | 145 | 2 | 574 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.79e-04 | 4 | 145 | 2 | 628 | |
| GeneFamily | CD molecules|Mucins | 6.04e-04 | 21 | 145 | 3 | 648 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.49e-04 | 181 | 145 | 7 | 694 | |
| GeneFamily | Cytosolic iron-sulfur assembly components | 9.38e-04 | 6 | 145 | 2 | 1028 | |
| GeneFamily | Gelsolin/villins | 1.73e-03 | 8 | 145 | 2 | 950 | |
| GeneFamily | Clustered protocadherins | 1.74e-03 | 64 | 145 | 4 | 20 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.91e-03 | 161 | 145 | 6 | 593 | |
| GeneFamily | Non-clustered protocadherins | 4.00e-03 | 12 | 145 | 2 | 21 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.31e-03 | 41 | 145 | 3 | 1298 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 5.46e-03 | 14 | 145 | 2 | 402 | |
| GeneFamily | Integrator complex | 6.26e-03 | 15 | 145 | 2 | 1366 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIF1A ATRX MAP1B MYCBP2 SEC24A C2CD5 LARP4B DST SYNE2 ZNF638 SUCO VCL USP24 APC SPG11 FRYL GIGYF2 TNKS PARD3 PLCE1 | 7.81e-06 | 856 | 197 | 20 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ATRX MAP1B MYCBP2 SYTL2 NFASC C2CD5 FSIP2 FAT2 ANKAR KCNK2 ANK3 MUC19 APC KIAA1549 GRID1 GRID2 PEX5L CELSR3 WDR97 VCAN TNKS FRMPD3 PCDH7 | 1.06e-05 | 1106 | 197 | 23 | M39071 |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 1.86e-05 | 196 | 197 | 9 | M8420 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 2.54e-05 | 77 | 197 | 6 | M40001 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MAP1B MYCBP2 TMEM132C DST ANAPC1 FAM161A VCL FAT4 ANK3 FAT3 APC LAMB3 GRID2 ARG1 SLCO5A1 CELSR1 VCAN GIGYF2 TNKS ASXL2 PCDH7 | 1.19e-05 | 806 | 190 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ATRX MAP1B MYCBP2 TMEM132C DST SUCO FAT4 ANK3 FAT3 APC LAMB3 GRID2 CPB1 ARG1 SLCO5A1 VCAN GIGYF2 TNKS ASXL2 PCDH7 | 3.86e-05 | 806 | 190 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 6.02e-05 | 149 | 190 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | MAP1B TMEM132C DST FAT4 ANK3 FAT3 APC GRID2 SLCO5A1 VCAN GIGYF2 TNKS ASXL2 | 8.09e-05 | 407 | 190 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | MAP1B TMEM132C DST FAT4 ANK3 FAT3 APC GRID2 CPB1 ARG1 VCAN GIGYF2 ASXL2 | 8.30e-05 | 408 | 190 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.52e-07 | 186 | 197 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-07 | 191 | 197 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 197 | 197 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-07 | 200 | 197 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-07 | 200 | 197 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-07 | 200 | 197 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 175 | 197 | 8 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 175 | 197 | 8 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 179 | 197 | 8 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 183 | 197 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.63e-06 | 183 | 197 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.70e-06 | 184 | 197 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 185 | 197 | 8 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 185 | 197 | 8 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 190 | 197 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.15e-06 | 190 | 197 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-06 | 191 | 197 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-06 | 191 | 197 | 8 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 191 | 197 | 8 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.33e-06 | 192 | 197 | 8 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.42e-06 | 193 | 197 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.42e-06 | 193 | 197 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 197 | 197 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 139 | 197 | 7 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 198 | 197 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.04e-06 | 199 | 197 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.04e-06 | 199 | 197 | 8 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 200 | 197 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 161 | 197 | 7 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 161 | 197 | 7 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.01e-05 | 168 | 197 | 7 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 168 | 197 | 7 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 173 | 197 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 173 | 197 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 173 | 197 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.32e-05 | 175 | 197 | 7 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 176 | 197 | 7 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 176 | 197 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.37e-05 | 176 | 197 | 7 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 177 | 197 | 7 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 180 | 197 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 180 | 197 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 181 | 197 | 7 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 181 | 197 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 181 | 197 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 182 | 197 | 7 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-05 | 182 | 197 | 7 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 186 | 197 | 7 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 125 | 197 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.02e-05 | 187 | 197 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 187 | 197 | 7 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 189 | 197 | 7 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.16e-05 | 189 | 197 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.16e-05 | 189 | 197 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-05 | 189 | 197 | 7 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 189 | 197 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 189 | 197 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-05 | 189 | 197 | 7 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 189 | 197 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 189 | 197 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 190 | 197 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 190 | 197 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.39e-05 | 192 | 197 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 192 | 197 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-05 | 192 | 197 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.47e-05 | 193 | 197 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 193 | 197 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.47e-05 | 193 | 197 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.47e-05 | 193 | 197 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.56e-05 | 194 | 197 | 7 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.56e-05 | 194 | 197 | 7 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-05 | 194 | 197 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.56e-05 | 194 | 197 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 194 | 197 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.56e-05 | 194 | 197 | 7 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 195 | 197 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 195 | 197 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.64e-05 | 195 | 197 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 195 | 197 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 195 | 197 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 195 | 197 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.64e-05 | 195 | 197 | 7 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 196 | 197 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 196 | 197 | 7 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 196 | 197 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 196 | 197 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 196 | 197 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 196 | 197 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| Disease | FEV/FEC ratio | TET2 DCHS2 IL18R1 MAP3K1 DST ARHGAP31 ANAPC1 NFIC ACAN SVIL SYNE2 CNTN2 HSPG2 TCP11 JMJD1C SLCO5A1 NPTN EPC1 LRP1 LTBP2 LTBP3 PARD3 | 1.65e-05 | 1228 | 191 | 22 | EFO_0004713 |
| Disease | cortical surface area measurement | TET2 DCHS2 MYCBP2 ADGRV1 CNTLN STAT1 MAP3K1 ARHGAP31 PKD1 KCNK2 DHX16 ANK3 FAT3 APC RPSA FRYL ARG1 CELSR1 VCAN TNKS PARD3 PCDH7 PLCE1 | 2.18e-05 | 1345 | 191 | 23 | EFO_0010736 |
| Disease | neuroimaging measurement | DCHS2 DPY19L3 MAP1B STAT1 MAP3K1 PLIN2 PKD1 KCNK2 HSPD1 ANK3 FAT3 APC RPSA FRYL JMJD1C CELSR1 VCAN PARD3 PCDH7 PLCE1 | 2.23e-05 | 1069 | 191 | 20 | EFO_0004346 |
| Disease | sexual dimorphism measurement | TET2 NCOA6 PNPT1 NFIC ACAN PKD1 ZNF638 SUCO COL7A1 KAT5 TCP11 APC FRYL JMJD1C GSS AVIL TNKS ASXL2 LTBP2 LTBP3 | 3.59e-05 | 1106 | 191 | 20 | EFO_0021796 |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 4.17e-05 | 2 | 191 | 2 | EFO_0021111 | |
| Disease | Colorectal Carcinoma | TET2 MAP1B PAIP2 KCNA10 PDILT COL7A1 APC LAMB3 GRID1 GRID2 PEX5L ABCC6 LRP1 GABPB1 | 2.08e-04 | 702 | 191 | 14 | C0009402 |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 2.48e-04 | 4 | 191 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | mean platelet volume | TET2 DIS3L PECAM1 NFASC UNC13D ZMIZ2 SVIL SYNE2 EDC3 PCDHGA10 PCDHGA7 FRYL JMJD1C PCDHGA12 EPC1 PCDHGA8 PLCE1 | 3.65e-04 | 1020 | 191 | 17 | EFO_0004584 |
| Disease | Squamous cell carcinoma of esophagus | 3.90e-04 | 95 | 191 | 5 | C0279626 | |
| Disease | apolipoprotein A 1 measurement | TET2 UNC13D MUC17 NFIC ZMIZ2 ANXA9 COL7A1 ITGA10 GRB14 SPG11 JMJD1C ARG1 SLC10A2 CELSR2 LRP1 | 4.41e-04 | 848 | 191 | 15 | EFO_0004614 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.50e-04 | 150 | 191 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | optic cup area measurement | 4.80e-04 | 56 | 191 | 4 | EFO_0006940 | |
| Disease | airway responsiveness measurement | 4.89e-04 | 24 | 191 | 3 | EFO_0006897 | |
| Disease | obsolete aging | 4.94e-04 | 279 | 191 | 8 | GO_0007568 | |
| Disease | mental development measurement | 5.53e-04 | 25 | 191 | 3 | EFO_0008230 | |
| Disease | 3-hydroxyisobutyrate measurement | 6.15e-04 | 6 | 191 | 2 | EFO_0010983 | |
| Disease | contactin-2 measurement | 6.15e-04 | 6 | 191 | 2 | EFO_0008100 | |
| Disease | varicocele (biomarker_via_orthology) | 6.15e-04 | 6 | 191 | 2 | DOID:12337 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.50e-04 | 291 | 191 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | epilepsy (implicated_via_orthology) | 6.96e-04 | 163 | 191 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | hereditary lymphedema (is_implicated_in) | 8.57e-04 | 7 | 191 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | cholesteryl ester 16:2 measurement | 8.57e-04 | 7 | 191 | 2 | EFO_0021435 | |
| Disease | cortical thickness | ANKRD13B MYCBP2 ADGRV1 STAT1 MAP3K1 PKD1 KCNK2 HSPG2 FAT3 RPSA JMJD1C CELSR1 VCAN LRP1 PARD3 PCDH7 PLCE1 | 9.64e-04 | 1113 | 191 | 17 | EFO_0004840 |
| Disease | creatinine measurement, glomerular filtration rate | 1.01e-03 | 117 | 191 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | stanniocalcin-1 measurement | 1.14e-03 | 8 | 191 | 2 | EFO_0020753 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 1.14e-03 | 8 | 191 | 2 | C3891448 | |
| Disease | ribose-5-phosphate measurement, ribulose-5-phosphate measurement | 1.14e-03 | 8 | 191 | 2 | EFO_0010529, EFO_0010530 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.17e-03 | 121 | 191 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | vital capacity | TET2 NCOA6 PIEZO1 UNC13D MAP3K1 PNPT1 DST ACAN KCNK2 HSPG2 EPB41L4B TCP11 JMJD1C LTBP2 LTBP3 PARD3 GABPB1 PLCE1 | 1.17e-03 | 1236 | 191 | 18 | EFO_0004312 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.18e-03 | 71 | 191 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.45e-03 | 127 | 191 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | peak expiratory flow | 1.59e-03 | 498 | 191 | 10 | EFO_0009718 | |
| Disease | testosterone measurement | TET2 NCOA6 DCHS2 NHSL2 UNC13D PLIN2 ANAPC1 FAM186A BSPH1 SYNE2 ANXA9 KAT5 ANK3 GRB14 LAMB3 JMJD1C GSS SUSD1 | 1.65e-03 | 1275 | 191 | 18 | EFO_0004908 |
| Disease | pulse pressure measurement | TET2 MAP1B PECAM1 UNC13D ZCCHC2 PLIN2 PNPT1 INTS11 PKD1 ZNF638 VCL FAT3 FRYL MTNR1B LRP1 LTBP2 LTBP3 PLCE1 CHMP1A | 1.81e-03 | 1392 | 191 | 19 | EFO_0005763 |
| Disease | otosclerosis | 1.92e-03 | 81 | 191 | 4 | EFO_0004213 | |
| Disease | forced expiratory volume | TET2 NCOA6 TDRD9 PIEZO1 CNTLN MAP3K1 PNPT1 DST ACAN KCNK2 PCDH15 TCP11 JMJD1C | 1.99e-03 | 789 | 191 | 13 | EFO_0004314 |
| Disease | creatinine measurement | TET2 HIF1A BRIP1 ADGRV1 LARP4B SVIL PDILT ANXA9 FBXO36 ARG1 CELSR3 CELSR2 GIGYF2 ASXL2 PARD3 | 2.17e-03 | 995 | 191 | 15 | EFO_0004518 |
| Disease | interleukin 1 receptor-like 1 measurement | 2.21e-03 | 11 | 191 | 2 | EFO_0008168 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 2.21e-03 | 11 | 191 | 2 | EFO_0801871 | |
| Disease | Complications of Diabetes Mellitus | 2.21e-03 | 11 | 191 | 2 | C0342257 | |
| Disease | hair colour measurement | PIEZO1 UNC13D ADGRV1 MAP3K1 SYNE2 RPSA GSS LRP1 ASXL2 PARD3 CHMP1A | 2.34e-03 | 615 | 191 | 11 | EFO_0007822 |
| Disease | Mitral valve prolapse, response to surgery | 2.64e-03 | 12 | 191 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 2.64e-03 | 12 | 191 | 2 | EFO_0010822 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.64e-03 | 12 | 191 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 2.85e-03 | 215 | 191 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip | 3.05e-03 | 92 | 191 | 4 | EFO_1000786 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.33e-03 | 222 | 191 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | lean body mass | 3.41e-03 | 379 | 191 | 8 | EFO_0004995 | |
| Disease | body weight | TET2 DPY19L3 ADGRV1 NFIC ACAN ZMIZ2 PKD1 PCDH15 ZNF638 EPB41L4B GRB14 GRID1 GRID2 SUSD1 LTBP2 LTBP3 PCDH7 | 3.55e-03 | 1261 | 191 | 17 | EFO_0004338 |
| Disease | glycodeoxycholate measurement | 3.60e-03 | 14 | 191 | 2 | EFO_0010493 | |
| Disease | receptive language perception, parental genotype effect measurement | 3.60e-03 | 14 | 191 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | hearing impairment | 3.83e-03 | 98 | 191 | 4 | C1384666 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.95e-03 | 49 | 191 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | biological sex | 3.96e-03 | 230 | 191 | 6 | PATO_0000047 | |
| Disease | coronary artery disease (is_implicated_in) | 4.11e-03 | 100 | 191 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 4.11e-03 | 100 | 191 | 4 | C0010606 | |
| Disease | depressive symptom measurement, stressful life event measurement | 4.18e-03 | 50 | 191 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | hair color | 4.29e-03 | 311 | 191 | 7 | EFO_0003924 | |
| Disease | epithelial cell adhesion molecule measurement | 4.43e-03 | 51 | 191 | 3 | EFO_0010574 | |
| Disease | Disease Exacerbation | 4.49e-03 | 165 | 191 | 5 | C0235874 | |
| Disease | Influenza | 4.67e-03 | 52 | 191 | 3 | C0021400 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 4.67e-03 | 52 | 191 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | tyrosine measurement | 4.73e-03 | 104 | 191 | 4 | EFO_0005058 | |
| Disease | interleukin 12 measurement | 4.93e-03 | 53 | 191 | 3 | EFO_0004753 | |
| Disease | phosphoglyceric acid measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0010523 | |
| Disease | cervical artery dissection | 5.32e-03 | 17 | 191 | 2 | EFO_1000059 | |
| Disease | banks of the superior temporal sulcus volume measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0010286 | |
| Disease | HOMA-B | 5.47e-03 | 55 | 191 | 3 | EFO_0004469 | |
| Disease | Leukemia, Myelocytic, Acute | 5.48e-03 | 173 | 191 | 5 | C0023467 | |
| Disease | JT interval | 5.69e-03 | 248 | 191 | 6 | EFO_0007885 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.75e-03 | 56 | 191 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 6.04e-03 | 57 | 191 | 3 | EFO_0022284 | |
| Disease | atopic eczema | 6.14e-03 | 252 | 191 | 6 | EFO_0000274 | |
| Disease | aspartate aminotransferase measurement | BRIP1 PIEZO1 FSTL4 NUBP1 ZNF638 ANXA9 CNTN2 DVL2 MUC19 GSS NPTN TNKS PLCE1 | 6.21e-03 | 904 | 191 | 13 | EFO_0004736 |
| Disease | triglycerides to total lipids in small VLDL percentage | 6.34e-03 | 58 | 191 | 3 | EFO_0022338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLVISIQREPVSAVS | 721 | O60241 | |
| RLTVPSSVATVNSIA | 756 | Q9H2F5 | |
| TIVADLSETTIQTPD | 376 | Q9NRG9 | |
| QLAVTEVATRPLVQD | 261 | O75366 | |
| ADRTLSVAVTPVQAV | 651 | Q9UJX6 | |
| VIDQTRLEATISPET | 1006 | P13611 | |
| TNPDLTQVVSLVVER | 136 | Q9NXG0 | |
| SLRTQPEVTSVASFI | 1441 | Q8IZF6 | |
| IPITSVINEFTENSL | 2261 | Q8IZF6 | |
| AVEPLSATVNVTVIL | 1076 | Q6V0I7 | |
| PSLISETTVTINIVD | 2961 | Q6V0I7 | |
| TVAVAVDTTLIPVET | 5141 | Q8WXG9 | |
| AVVESAVVSSPDQIR | 496 | P0C7M7 | |
| ASLLTTAEVVVTEIP | 536 | P10809 | |
| VLVVQATSAPLVSRA | 1071 | Q9NYQ6 | |
| TIVTPNIVISVVRLD | 2161 | Q9HCU4 | |
| VTNRIDTTRVEFTIP | 196 | Q6ZPD9 | |
| TIGRTVTTDLQIVEL | 931 | Q6Q4G3 | |
| LDVVTPESFTQLSRV | 1231 | Q9P1Z9 | |
| PDVQTLRAFTTELVV | 21 | O60826 | |
| ELEETTVPEIQRTSL | 746 | O60231 | |
| NLEPETETESVVSLR | 146 | O14641 | |
| EASLIRIVPVVSQSE | 416 | Q76L83 | |
| FTLVSRTPEQVTVRL | 736 | O94823 | |
| PEEVTRTVNTAVAIT | 286 | P05089 | |
| PDIIVFITSAETVNI | 1491 | Q9ULI1 | |
| ISTDSAVASPQRIQI | 11 | P49116 | |
| ATVTLTVAVADSIPE | 656 | Q9Y5G6 | |
| LPTNVQVEVITIEST | 156 | Q9HBI0 | |
| RSSTSPSIINEDVII | 6 | Q9BPZ3 | |
| ITVTVEEQRSQSVRP | 1771 | P98160 | |
| ARIQVVVLSASDASP | 2036 | P98160 | |
| VPETIELEVRTSTAS | 4226 | P98160 | |
| RTPVETVNISNELIS | 381 | P21918 | |
| ATVTLTVAVADSIPE | 656 | Q9Y5G5 | |
| ATVTLTVAVADSIPQ | 656 | O60330 | |
| VQILNITISSSRVTP | 1091 | Q9HCM3 | |
| TSSSIRTVDLIPVDQ | 1101 | Q6ZRR7 | |
| VIITTPQEVSLQDVR | 196 | P53384 | |
| TITSDITNVSRPRIV | 1401 | Q7Z5J8 | |
| RITIPEIATSELVQT | 606 | Q9H1A4 | |
| FERSNTNPSVTVITI | 721 | O43747 | |
| TEEQVLSRLTAPVVT | 226 | Q86YJ7 | |
| ATTLTTPQEQVDSLI | 136 | Q9HD42 | |
| ATVPEQRTVTLDVDV | 1346 | O75140 | |
| LVTSSRAVISTTIPI | 10881 | Q8WXI7 | |
| VFPQVSETTASLTIR | 11791 | Q8WXI7 | |
| EGIPIRTTLDNSTTV | 26 | Q8TF09 | |
| LSVVEVSFSAVITPE | 66 | P58181 | |
| TFNITIVEDRSNIVP | 201 | Q13478 | |
| VLINPSDEAVSTEVR | 111 | P46821 | |
| SSSTLVEVTLREVPA | 41 | P43365 | |
| LQTVSSSPVTEISRE | 396 | Q5T3J3 | |
| SSPVTEISREVVNIV | 401 | Q5T3J3 | |
| VTVESVLLQAAAPSE | 551 | Q5TA45 | |
| RITTSQLVNEASTVP | 3181 | Q03001 | |
| SDINPVLVSSDRVEI | 376 | Q5VTL7 | |
| LSVALSQRTTVPEEE | 691 | Q16665 | |
| IISFTVPDIDNVTVL | 1606 | Q07954 | |
| ITPVNESVVSSARAV | 1636 | Q5HYC2 | |
| LVERNIPSSVTAVEF | 116 | Q15652 | |
| LDQPVSQTRTTAIVE | 1606 | Q2LD37 | |
| QVLTVPATDIAEETV | 306 | Q06547 | |
| RPQITINEISEITSI | 436 | Q92993 | |
| PTVLASRVESDTTIN | 41 | O95069 | |
| TLSADASVNTLPVVV | 566 | Q92615 | |
| PALSAVLIVTTAVDV | 41 | P49286 | |
| DPVSTIVTQVLSEVI | 4276 | Q5CZC0 | |
| ISALTITPDRENVVD | 521 | O43424 | |
| QRVPARVLDTDTITQ | 1536 | Q9ULL4 | |
| PSLQSEEEVLVTVRN | 2151 | Q9NYQ8 | |
| RSEVVSLFVTVPVSR | 551 | Q96RD9 | |
| SQPETTVVATREVET | 8131 | Q7Z5P9 | |
| TVTLTVAVADSIPQV | 661 | Q9Y5H3 | |
| VLVDTPIALVQVSDR | 436 | O60245 | |
| TTVRPLIEVQLSEEQ | 1241 | Q92614 | |
| SEAIARPVTSNTAVL | 91 | Q8IYB4 | |
| VIAPVDEVQISILSS | 496 | P16284 | |
| TTEEVLQIRDETPTL | 2536 | O94915 | |
| QIVQSTCDTITPDVR | 136 | Q8NEA4 | |
| LPTVRSTRIVEEADV | 351 | Q9H0H0 | |
| SAVDVAIEILATRTP | 131 | O76027 | |
| SAVDQVSQTISLTRP | 26 | Q96F86 | |
| NVIVTERVIAPSSSL | 891 | Q02413 | |
| ESSNVVVTERVIQPT | 916 | Q02413 | |
| FPTVSLVDSTLVEVV | 1656 | P16112 | |
| LVDRTLVESVTQAPT | 1936 | P16112 | |
| DRESIPTVILTVTAS | 1576 | Q6V1P9 | |
| SPTNQTTVIVRADDL | 2051 | Q6V1P9 | |
| EEAREVPVISASTQI | 511 | Q9BX63 | |
| SIVTTLVPSELISAV | 1916 | Q14686 | |
| TVTVTTEPENRSLTI | 16 | O60927 | |
| FATLITELVQETEPS | 316 | Q16322 | |
| TAIAATTEATTVPII | 1056 | O94856 | |
| TVSRTVELKSEPNVI | 1676 | Q96QU1 | |
| TLTVEVSVETIRNPQ | 91 | O95816 | |
| VEATNSVTAVRIQPL | 2336 | P46100 | |
| SVTAVRIQPLEDIIS | 2341 | P46100 | |
| TAVDPVADIATLRIQ | 221 | O43464 | |
| TESPVRTLQVETLVE | 31 | Q9NYL4 | |
| IQVEITPTSSRISRN | 301 | Q9BYI3 | |
| PESSQAARVLAVVSV | 136 | Q96RP8 | |
| SDQNIIPSVTRSVSV | 671 | Q6Y7W6 | |
| PVILNELSSTVETIT | 21 | Q075Z2 | |
| DEIPVTLIDSVQTRT | 736 | Q5JV73 | |
| TVVVSPDIVTIDLNT | 291 | Q8NCL4 | |
| TILVENSISVIPFSE | 426 | Q8TF46 | |
| QLSLAPEDRVSVTTV | 246 | Q6MZW2 | |
| TIAESTPLRTSVAQV | 166 | Q8TDW7 | |
| TPLRTSVAQVTATDA | 171 | Q8TDW7 | |
| TVETNLERNVETPTV | 3666 | Q12955 | |
| TEILVNSSRVTVTPD | 456 | Q02246 | |
| VVETQDLASPVLRSV | 181 | Q5I0G3 | |
| QEEQVTPSTDVLVTL | 826 | Q14767 | |
| SRSAVEIAPTQVTET | 561 | Q9NS15 | |
| ALTVRPEIVSITSFN | 391 | Q5VSG8 | |
| SLEVTPQAISVVQRD | 651 | O75578 | |
| TLDSSVLEEVQRSPV | 191 | Q8NEG0 | |
| AISAITITPERESVV | 516 | Q9ULK0 | |
| EEGVISTLTISNIVR | 476 | Q8IZU9 | |
| SRVIENPTEALSVAV | 386 | Q14449 | |
| LTDPQIRQISESTAV | 1026 | Q9ULL0 | |
| IEQIRAVLSSPAVTE | 631 | Q13751 | |
| ARTDASVEQTLRPVI | 411 | Q02388 | |
| QVPDTSVQETDRILV | 51 | Q5J8M3 | |
| AETVTQTQPVRLLSS | 71 | Q96AY2 | |
| LVQVRSFVLPVESTQ | 546 | Q9Y4K1 | |
| LAEIESERDIPTVST | 796 | A6NE01 | |
| VVQATSAPLVSRATV | 1141 | Q9NYQ7 | |
| VQPVVIREDSLSDSS | 126 | Q3B820 | |
| VLLRTSQEPTSSEVV | 31 | P48637 | |
| VLQEPTAFRISVTSS | 66 | Q86Y30 | |
| LIEQVPSTTSVIERN | 276 | Q1W6H9 | |
| LVSIVTEFVSNPATI | 511 | Q9UKG4 | |
| ATLRPLTETVSTVQT | 851 | Q9H329 | |
| QVATENPALISRSVI | 131 | P15086 | |
| TVSLPEDELIQVTVT | 776 | Q86YS7 | |
| VRVQVSDPESTVAVA | 71 | Q9Y3D0 | |
| QLSAAIPATRVEVSV | 16 | Q86YQ8 | |
| SRQLEFEATSVTVIP | 371 | Q3KNS1 | |
| DSALVEVQEPVLVTS | 1456 | P98161 | |
| PLTSNVTVFVSIIDQ | 581 | Q9BZA8 | |
| LIATFDEPRTVVSTV | 661 | Q96RD6 | |
| ATSEIEVTPSVLRAN | 121 | Q8TEW0 | |
| STIVQLSFTPEELNV | 271 | Q12908 | |
| VDNLIIVVTITTSPA | 61 | Q8NGB2 | |
| SIPAEVTTIRISITS | 3856 | Q685J3 | |
| TVNESSVTLDPAVRT | 361 | Q9ULK6 | |
| IVSTDVSQAEPVEIR | 776 | Q13233 | |
| SSEQVAEFVISRPLV | 161 | Q8N807 | |
| VAIENPADVSVISSR | 66 | P08865 | |
| ELVRSAEDVSTVPTQ | 531 | Q9HCH5 | |
| PADILTETINTVSEV | 326 | O60763 | |
| VTLSVIASPVIAAVS | 406 | Q6ZMZ0 | |
| IDLETTSLPVVVISN | 446 | P42224 | |
| ILSESVVPDVRSVVT | 206 | Q969G3 | |
| QDRSLTQPITTEEVV | 731 | O95425 | |
| TQPITTEEVVIAATE | 736 | O95425 | |
| AVTAVVTAEEVLRTP | 691 | Q8N3T6 | |
| QESETLIIPRVETAA | 2851 | Q8WXH0 | |
| SVREREVPISLEVSQ | 571 | O15061 | |
| IILSTNIAESSVTVP | 441 | Q8NDG6 | |
| TSRATTPSQLSIEVE | 681 | Q5HYW2 | |
| TPSQLSIEVEAREIS | 686 | Q5HYW2 | |
| VSLVVAVATPLATVA | 1076 | O95255 | |
| TVIKAPRVSTAQDVI | 2151 | Q9P212 | |
| DLVQLPVVTSSTIVR | 416 | O95486 | |
| QPSAIIVTLRSVEDE | 666 | Q9H2Y9 | |
| SVRILSVSPIQAEQE | 151 | Q9HAT2 | |
| VTPTRTEIIILATRT | 41 | P23396 | |
| VVRIFATSTEPVLQQ | 481 | O75592 | |
| FSVTELIQVSRTPVV | 226 | P08651 | |
| VLQSPATTVVRTLND | 751 | Q8TCS8 | |
| TIVLPESTSLQVVQR | 91 | Q96GA7 | |
| SRSIVSTAPQEVLQT | 246 | Q9UPE1 | |
| ALTSQEEDPVLTVIT | 346 | Q9BY15 | |
| VPVSETNESSIVERT | 2746 | P25054 | |
| SVRTSVVTQQLLSEP | 21 | Q96AQ7 | |
| QVQRPLVSVTVSDAS | 191 | Q9Y679 | |
| VAISAIRESANSTPV | 756 | Q9C0B9 | |
| TVPSSNEVVTNLEVL | 1966 | Q96JI7 | |
| QSLVERTVSETDIIP | 1621 | A4UGR9 | |
| SRPEEAILTVSEQVS | 371 | Q8WWU5 | |
| TVRSIQEAPVSEDLV | 176 | Q5JTV8 | |
| TEIDSPTNVVTDRVT | 441 | Q9UQP3 | |
| RAEVSTAAQTVPTAL | 916 | A6NE52 | |
| SELPVVISLTTQITE | 571 | Q6UWL2 | |
| QQILSESTPIRTSDV | 636 | O95271 | |
| TISVLQKPRIVTSEE | 141 | Q9Y639 | |
| TVNVVPVIARADSLT | 186 | Q8IYM1 | |
| TRTIESILEPVAQQI | 6 | P18206 | |
| VDETTPAVVQSVLLE | 91 | Q9BWV7 | |
| AVSVPLRVSAVISTN | 491 | Q2M1Z3 | |
| QTLISVVDSSSLPEV | 851 | Q9UBS9 | |
| RQALAVPTDSAVTVS | 1766 | O43151 | |
| QSTARVVVVFSPDLT | 266 | Q8TE23 | |
| TSFSIPVVSDVRELV | 176 | Q92979 | |
| TILVPLVQEIESVST | 346 | Q96SK2 | |
| SVQVSVNATPLTIER | 486 | Q8NF64 | |
| PVILTTIQDVRSVEE | 336 | Q9UPU5 | |
| VAIVSQPVARSSVSA | 596 | Q6PF04 | |
| IRPQESATVSEKVLV | 1126 | Q9UL36 | |
| SVVTRVVNLPLVSST | 11 | Q99541 | |
| VTVADTEPTRTQTLL | 551 | Q92508 | |
| LEPEIAQATSSRTVV | 321 | Q8TD22 | |
| ASIETITTTIQDLFP | 426 | Q9UN76 | |
| PVTVLTRQTTAAELD | 1061 | Q6N021 | |
| PEEETHRTQVITQTL | 166 | Q70J99 | |
| EEIPLVASASVSIEQ | 1176 | Q14966 | |
| TTLTITVPAVSRRVE | 181 | Q9P2T0 | |
| ARIQEIVVETPTLAA | 366 | Q5T124 | |
| TISLVVVPSNVDIAT | 211 | P20591 | |
| SLIFQVEAVEVTPLS | 316 | O15069 | |
| VVVRLPSVSDVSEET | 2296 | B2RTY4 |